This is significant -- as it is now the second Merck Vaccines executive (or ex-executive), to be named -- as a tipper -- in two separate SEC Insider Trading investigations.
I'll have more soon, but The Wall Street Journal has the scoop on Merck's James W. Self:
. . . .Mr. Goldfield, 46 years old, made about $14 million from the trading in question, but later lost all of it, the SEC said. The agency named Mr. Goldfield's friend, James W. Self, Jr., 45, as the second defendant, accusing him of illegally sharing information he gained as an executive at a third pharmaceutical company that was privy to details of a potential MedImmune acquisition.
According to materials on the website of Merck & Co., James W. Self is an executive director there, overseeing business development related to the firm's vaccine division. A message left with Mr. Self's assistant at Merck wasn't immediately returned. A Merck spokesperson wasn't immediately reached for comment. . . .